Loading clinical trials...

Five Point Initiative: A Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities | Clinical Trials | Clareo Health

RECRUITINGNA

Five Point Initiative: A Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities

Five Point Initiative: A Cluster Randomized Trial of a Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities

NCT06062342•University of Miami

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess the effectiveness of the FPI bundled implementation strategy in increasing HIV testing, Pre-exposure prophylaxis (PrEP) linkage (e.g., prescription) and knowledge, and condom use/access.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Any individual present during the community events at the "five points" (barbershop, hair/beauty salon store or salon, corner store/grocery/neighborhood restaurant, laundromats, car service provider \[e.g. gas station, mechanic, car wash\]) in predominantly Black communities in Miami where HIV prevalence is high.
•Pre- and Post-assessment: Individuals are only eligible to complete the survey one time during the Pre-Intervention and during the Post-Intervention phases.
•Intervention: Individuals are only eligible to participate in the Intervention phase of this study once every 6 months.

Exclusion Criteria

•Individuals who are unable to completely and fully understand the informed (verbal) consent process and the study procedures.
•Individuals who have previously completed the survey during the Pre-Intervention and Post-Intervention phases.
•Individuals who have participated in the Intervention phase of this study within less than 6 months.

Locations (1)

University of Miami

Miami, Florida, United States

Key Dates

Start Date

February 2, 2024

Primary Completion Date

December 1, 2028

Completion Date

June 30, 2029

Last Updated

July 29, 2025

Enrollment

20,400

ESTIMATED participants

Conditions

Hiv

Interventions

FPI

BEHAVIORAL

Contacts

Sannisha Dale, PhD

CONTACT

(305) 243-6714 sdale@med.miami.edu

SHINE Research Program

CONTACT

shineresearch@miami.edu

Thinking and Memory Problems in People With HIV

NCT01875588

HIV Positive

View study

RECRUITINGPHASE2

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

NCT04929028

View study

RECRUITING

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 29, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Five Point Initiative: A Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities

Inclusion Criteria

Exclusion Criteria

Thinking and Memory Problems in People With HIV

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs

The LD Lync Study - Natural History Study of Lipodystrophy Syndromes

Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption